- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Attacks in Adolescents and Adults with Hereditary Angioedema.
This study is testing a new soft capsule medicine for people with Hereditary Angioedema (HAE) to quickly stop attacks. It compares the new medicine, called deucrictibant, with a dummy capsule (placebo) and another existing medicine to see how fast it relieves symptoms.
For: Hereditary AngioedemaPoland · Germany · Austria - AuthorisedTherapeutic exploratory (Phase II)
A randomized, double-blind crossover study to investigate the analgesic efficacy of the bradykinin (B2) antagonist icatibant for propofol injection pain in healthy adult participants.
This study is looking for healthy adults to test a new medicine idea, icatibant, to see if it can reduce the stinging pain sometimes felt when having an injection of propofol, a medicine used for sleep during medical procedures.
For: PainNorway